Taiyen Biotech Co., Ltd. (TPE:1737)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.90
-0.05 (-0.16%)
At close: Jul 9, 2026
Market Cap6.38B -3.0%
Revenue (ttm)3.28B +1.0%
Net Income397.04M +9.0%
EPS1.97 +8.2%
Shares Out 200.00M
PE Ratio16.19
Forward PEn/a
Dividend1.40 (4.38%)
Ex-Dividend DateAug 20, 2025
Volume85,872
Open31.95
Previous Close31.95
Day's Range31.85 - 32.00
52-Week Range30.80 - 33.45
Beta0.14
Analystsn/a
Price Targetn/a
Earnings DateAug 3, 2026

About Taiyen Biotech

Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers seawater chemicals; toothpaste, mouthwashes, and eyeglass solutions; beverages; bottled water; medical supplies; food and food additives; beauty, skincare, and cleaning products; and salt products; as well as health food and health products. The company was founded in 1952 and is based in Tainan City, Taiwan. [Read more]

Founded 1952
Employees 450
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1737
Full Company Profile

Financial Performance

In 2025, Taiyen Biotech's revenue was 3.31 billion, an increase of 2.15% compared to the previous year's 3.24 billion. Earnings were 399.87 million, an increase of 7.63%.

Financial Statements